2 Results Sort by:
Novel Therapeutic Target for Fragile X Syndrome and Neurodevelopmental Disorders
Application Salvianolic acid C for treating Fragile X Syndrome (FXS). Key Benefits New therapeutic drug candidate for the treatment of FXS. Preliminary data in the laboratory in organoids treated with the drug showed rescued cell phenotypes known to be associated with the disease in humans. Potential to treat other neurodevelopmental disorders. Market...
Published: 9/3/2025       Contributor(s): Peng Jin, Chuan He, Zhongyu Zou
Neuroimaging Technique for Early Detection and Diagnosis of Parkinson’s Disease
Application A quantitative, non-invasive, multi-modal, MRI-based diagnostic for Parkinson's disease. Key Benefits There is no diagnostic for Parkinson's disease - current blood tests and MRIs rarely reveal abnormalities in patients. Provides a quantitative MRI-based diagnostic as well as potential early (pre-symptomatic) diagnostic tool...
Published: 9/3/2025       Contributor(s): Daniel Huddleston, Xiaoping Philip Hu, Sinyeob Ahn, Xiangchuan Chen